The discovery of RNA silencing as a sequence-specific gene regulation mechanism in eukaryotes has been heralded as the most exciting breakthrough in current biology. The seminal work of Baulcombe and Hamilton in 1999 provided a key insight into the potential function of a tiny RNA species of approximately 25 nucleotides (nt) in RNA silencing in plants [1] . Subsequently, Tuschl and colleagues [2, 3] demonstrated that small RNAs of similar size mediated RNA interference (RNAi) in insect and mammalian cells. These discoveries uncovered a previously unrecognized small RNA world and led to a surge in interest in small RNA biology. Now small RNAs are well recognized as ubiquitous, versatile regulators of gene expression in plants, fungi and animals [4, 5] .
On the basis of their origins, biogenesis and mode of action, small RNAs can be categorized into three major classes: small interfering RNAs (siRNAs), microRNAs (miRNAs) and Piwi-associated interfering RNAs (piRNAs). siRNA is about 21-24 nt in size and is processed from a perfect base-paired double stranded RNA (dsRNA) precursor by RNase III-like enzymes termed Dicers [6] . miRNA is also a cleavage product of Dicer enzymes from an imperfect RNA hairpin formed through inter-molecular base-pairing and is mostly 21 nt long [7] . piRNA is generated in a Dicerindependent manner with longer size (from 24 to 32 nt) than miRNAs and siRNAs, and is highly enriched in animal germ line cells [8] . Genetic and biochemical studies in Arabidopsis thaliana, Caenorhabditis elegans, Drosophila melanogaster and other model organisms have provided frameworks of small RNA-mediated regulation mechanisms. In brief, these small RNAs associate with a diverse of proteins from the Argonaute family and form the core RNA silencing processor called RNA-induced silencing complexes (RISCs). Small RNAs guide the RISCs to search for target RNAs by base pairing and cause degradation or translation inhibition of cognate mRNAs, or changes in chromatin structure [9] .
Plants are particularly rich in diversity of small RNAs. Thus far several different types of endogenous small RNAs have been identified in plants: trans-acting siRNAs (tasiRNAs), natural antisense transcripts-derived siRNAs (natsiRNAs), heterochromatic siRNAs (hc-siRNAs), long siRNAs (lsiRNAs) and miRNA [10] . These small RNAs participate in virtually every aspect of plant life, such as development timing [11, 12] , chromatin remodeling [13, 14] , genome protection [15] as well as responses to biotic and abiotic stresses [16] [17] [18] .
In plants, small RNAs can also be produced from invading exogenous nucleic acids such as viruses, and these virus-derived siRNAs target cognate RNAs for specific degradation [19, 20] . If a recombinant virus harboring a sequence fragment of a plant gene, the cognate endogenous mRNAs can be degraded upon virus infection [21] . This principle inspires scientists to develop a novel reverse genetics tool known as virus-induced gene silencing (VIGS). VIGS represents a simple, fast and transformation-free approach for gene loss-of-function assay, and has been widely used for plant functional genomics, especially in species that are less amenable to traditional genetic manipulation [22] [23] [24] . On the other hand, the small RNA-mediated natu-ral antiviral response in plants can be reinforced by expressing a sequence of viral origin that potentiates the host RNA silencing defense mechanism [25] . This strategy, which is known as pathogen-derived resistance, has been very successfully utilized in molecular breeding program for viral disease resistance even long before our mechanistic understanding of RNA silencing [26, 27] . One outstanding example is the control of Papaya ringspot virus in Hawaii by transgenic expression of viral coat protein gene in papaya plants [28] . While Fire and Mello [29] made the breakthrough discovery in 1998 that dsRNA is the trigger of RNA silencing, Waterhouse et al. [30] showed that transgenic expressing a dsRNA structure derived from a viral sequence effectively induced RNA silencing and conferred specific virus immunity. Since then, this approach has been well adopted for genetic engineering for crop resistance to infections of all major classes of plant viruses [31, 32] . In an analogous process termed host-induced gene silencing (HIGS), transgenic expression of dsRNAs in plant triggers robust silencing of cognate mRNAs expressed by invading fungi [33, 34] , nematode [35, 36] , parasitic plant [36, 37] and even chewing insects [38, 39] . HIGS has emerged as a promising strategy to create transgenic germplasm for pest control [40] . In addition, small RNA-based technologies can be harnessed to modify crop agronomic trait to enhance stress tolerance and to increase yields [41, 42] . Studies of viral counter-defense measure led to the discovery of viral suppressors of RNA silencing. These suppressors not only facilitate our better understanding of RNA silencing pathway [43] [44] [45] , but also serve to increase foreign protein production in transgenic plants [46] .
In animals, the biogenesis and function of miRNAs have been studied extensively. Animal miRNAs have more relaxed base-pairing requirements and thus regulate greater numbers of target mRNAs than their plant counterparts do. Another different aspect of animal miRNAs is that their targets are often subjected to translation repression instead of RISC-mediated destruction [47] . It is estimated that human genome gives rise to well over 800 mature miRNAs [48] . Each miRNA may regulate hundreds of genes and a majority of genes may be controlled by one or more miRNAs [7] . The normal miRNA activities are needed in proper regulation of many cellular processes ranging from cell differentiation to apoptosis, whereas dysregulation of miRNA expression is associated with various disease conditions [49] . Therefore these miRNAs may serve as novel diagnostic biomarkers [50] and therapeutic targets [51] . One such example is the development of a locked nucleic acid-based antisense oligonucleotide "Miravirsen" that specifically inhibits miR-122 [52] , a liver specific miRNA that is required for Hepatitis C virus replication [53] . Report from the Phase IIa clinical trial showed that Miravirsen provided robust dose-dependent anti-viral activity that was maintained beyond the end of therapy [54] , highlighting the therapeutic potential of miRNA-based medicine.
Although the diversity and function of endogenous siRNAs in human cells have not been fully delineated, it has been well established that the RNAi machinery can utilize exogenous siRNAs to shut off human gene expression [2] . This has led to the siRNA-based RNAi approach that now has been routinely used in both basic and applied studies [55] . Numerous genome-wide RNAi screenings with synthetic siRNA molecules have begun to systemically identify important genes implicated in various cellular pathways [56] . An important practical consideration is that knocking down the abnormal expression of disease-causing genes by administrated siRNA drugs may offer clinical benefits. By 2011, nearly 30 small RNA-based therapeutic agents had undergone clinical trials for treatment of various diseases, including cancers, physiological and metabolic disorders and viral infections [57, 58] . The bench-to-bedside translation of small RNA biology can be anticipated in the near future.
Since the discovery of RNA silencing, research on small RNAs is probably one of the most rapidly advancing fields in the contemporary biology. Numerous efforts have been made to uncover the repertoire and diversity of small RNAs in the past 15 years. This process is greatly expedited by the technical advances in high-throughput deep sequencing of small RNA, leading to an information explosion in the small RNAome [59] . The availability of newly annotated genome sequences also contribute to small RNA profiling through comparative genomics analyses [60, 61] . With the everincreasing small RNA species, a major challenging problem is to identify the targets of small RNAs and to annotate their functions. Genetic and biochemical dissection of RNA silencing pathway in model organisms will continue to expand our appreciation for the small RNA-mediated regulatory mechanisms. Improvement of current computational algorithms will likely facilitate our understanding of more comprehensive miRNA targetome [62] [63] [64] . New advances in RNA-Seq technologies may enable the experimental examination of changes in target gene expression when miRNA level is deliberately altered [63, 65] . Development of methods for real-time monitoring small RNA activities in vivo may provide new insights into their functions in normal physiology and disease [66] [67] [68] . Breakthroughs in small RNA delivery methodology could increase its efficacy and minimize side effect [69] . We can anticipate that advances in fundamental small RNA biology will make a big difference in agricultural biotechnology and biomedicine. 
